All these tools Thought Machine , Exscientia offer flexible pricing models suitable for Direct-to-Consumer (DTC) Brands, B2B Retailers, Small to Medium Enterprises (SMEs), Large Enterprises, Subscription Box Companies, Health & Beauty Brands, Food & Beverage Companies, Furniture & Home Goods Brands seeking AI-powered solutions to enhance their Custom Packaging Services efforts.
Thought Machine
Exscientia
These AI tools are among the best Custom Packaging Services tools available in 2025. For Direct-to-Consumer (DTC) Brands, B2B Retailers, Small to Medium Enterprises (SMEs), Large Enterprises, Subscription Box Companies, Health & Beauty Brands, Food & Beverage Companies, Furniture & Home Goods Brands, tools like Thought Machine , Exscientia help streamline the Custom Packaging Services process by offering AI-powered features.
What is Thought Machine?
Thought Machine, founded in 2014 by Paul Taylor in London, UK, is a trailblazing fintech company revolutionizing banking with its Vault Core cloud-native banking platform. Its flagship products, Vault Core and Vault Payments, empower banks to modernize legacy systems, delivering unparalleled flexibility through a microservices-based, cloud-agnostic architecture. Trusted by global giants like JPMorgan Chase, Lloyds Banking Group, and Intesa Sanpaolo, Thought Machine serves over 30 countries, processing millions of transactions with a $2.7 billion valuation and $500 million in funding. Its scalable core banking solutions enable rapid product launches, cutting costs by up to 50% and reducing time-to-market from months to days.
What is Exscientia?
Exscientia, founded in 2012 in Oxford, UK, is a trailblazing AI-driven drug discovery platform for precision medicine that leverages artificial intelligence to revolutionize pharmaceutical development. Acquired by Recursion Pharmaceuticals in November 2024, Exscientia combines AI, automation, and patient-centric data to design safer, more effective drugs faster. With over $450 million in milestone payments and a pipeline of more than 10 clinical and preclinical programs, patient-first AI for drug development has delivered the first three AI-designed drugs to clinical trials, achieving 10 times productivity gains. Trusted by partners like Sanofi and Bristol Myers Squibb, Exscientia operates globally, focusing on oncology and beyond.
-
Accuracy and Reliability:
4.7
-
Cost-Efficiency:
4.5
-
Customization and Flexibility:
4.8
-
Data Privacy and Security:
4.7
-
Ease of Use:
4.9
-
Functionality and Features:
4.6
-
Integration Capabilities:
4.5
-
Performance and Speed:
4.4
-
Support and Resources:
4.8
-
Accuracy and Reliability:
4.7
-
Cost-Efficiency:
4.5
-
Customization and Flexibility:
4.8
-
Data Privacy and Security:
4.6
-
Ease of Use:
4.5
-
Functionality and Features:
4.4
-
Integration Capabilities:
4.3
-
Performance and Speed:
4.2
-
Support and Resources:
4.7
Thought Machine
Launches products in days.
98% uptime with real-time processing.
Highly configurable smart contracts.
Seamless AWS and Azure integrations.
Supports 200+ preconfigured products.
Requires technical expertise.
High costs for smaller banks.
Minor migration issues.
Peak-time support delays.
Exscientia
10x faster drug discovery.
95% accurate drug response predictions.
30% cost reduction in R&D.
Scalable AWS-powered platform.
Strong partnerships with Sanofi and Merck.
Requires technical expertise.
Minor third-party data privacy risks.
High initial costs for small firms.
Occasional support delays.
If you're looking for other Custom Packaging Services tools for Direct-to-Consumer (DTC) Brands, B2B Retailers, Small to Medium Enterprises (SMEs), Large Enterprises, Subscription Box Companies, Health & Beauty Brands, Food & Beverage Companies, Furniture & Home Goods Brands, you can also explore Flowspace, which are highly rated in 2025.
- Thought Machine
- London, UK
- Exscientia
- Oxford, UK


